(Q38040323)

27 August 2017

title

Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis (English)

1 reference

27 August 2017

0 references

hepatocellular carcinoma

1 reference

1 reference

2

Takuji Tanaka

1 reference

27 August 2017

Masahito Shimizu

1

1 reference

27 August 2017

Hisataka Moriwaki

series ordinal

3

1 reference

27 August 2017

publication date

4 September 2012

1 reference

Seminars in Immunopathology

27 August 2017

published in

1 reference

27 August 2017

volume

35

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

191-202

1 reference

Nonalcoholic fatty liver disease

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Obesity, inflammation, and liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients: A prospective, case series study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Obesity and diabetes as a risk factor for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Nutraceutical approach for preventing obesity-related colorectal and liver carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Current understanding of insulin resistance in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Abnormalities of lipid metabolism in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Metabolic disturbances in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Insulin can block apoptosis by decreasing oxidative stress via phosphatidylinositol 3-kinase- and extracellular signal-regulated protein kinase-dependent signaling pathways in HepG2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Pitavastatin suppresses diethylnitrosamine-induced liver preneoplasms in male C57BL/KsJ-db/db obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Interleukin-6 induces cellular insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Interleukin-1beta may mediate insulin resistance in liver-derived cells in response to adipocyte inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Leptin regulation of the immune response and the immunodeficiency of malnutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Increased oxidative stress in obesity and its impact on metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

JNK1 but not JNK2 promotes the development of steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Influence of obesity on the risk of developing colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

(-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Branched-chain amino acids as a protein- and energy-source in liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Branched-chain amino acids as pharmacological nutrients in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Tea, obesity, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

The effects of green tea on weight loss and weight maintenance: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Cancer prevention by tea: animal studies, molecular mechanisms and human relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Chemoprevention of hepatocellular carcinoma by acyclic retinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Branched-chain amino acids prevent insulin-induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

(-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

International Union of Pharmacology. LXIII. Retinoid X receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

International Union of Pharmacology. LX. Retinoic acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

The promise of retinoids to fight against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

RAR and RXR modulation in cancer and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Phosphorylated retinoid X receptor alpha loses its heterodimeric activity with retinoic acid receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0336-6

Expression of retinoid X receptor alpha is decreased in 3'-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats

21 January 2018

1 reference

12 December 2020

Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model

1 reference

12 December 2020

The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice

1 reference

12 December 2020

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis

1 reference

12 December 2020

Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma

1 reference

12 December 2020

Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?

1 reference

12 December 2020

Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice

1 reference

12 December 2020

Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease

1 reference

12 December 2020

Obesity management--an opportunity for cancer prevention

1 reference

12 December 2020

The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses

1 reference

12 December 2020

Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma

1 reference

12 December 2020

Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.

1 reference

12 December 2020

The chemopreventive effects of tea on human oral precancerous mucosa lesions

1 reference

12 December 2020

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

1 reference

12 December 2020

Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis

1 reference

12 December 2020

Inhibition of Raf-1 kinase expression abolishes insulin stimulation of DNA synthesis in H4IIE hepatoma cells.

1 reference

12 December 2020

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

12 December 2020

EGCG and Polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS.

1 reference

12 December 2020

10.1007/S00281-012-0336-6

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1012622091

0 references

1 reference